✦ LIBER ✦

Adjuvant chemotherapy with 5-fluorouracil, doxorubicin and mitomycin-C (FAM) for 6 months after curative resection of gastric carcinoma

✍ Scribed by D.H. Koo; J.L. Lee; T.W. Kim; H.M. Chang; M.H. Ryu; J.H. Yook; S.T. Oh; B.S. Kim; J.S. Lee; Y.K. Kang

Book ID: 116442881
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 238 KB
Volume: 33
Category: Article
ISSN: 0748-7983
DOI: 10.1016/j.ejso.2006.11.030

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

OK-432 and 5-fluorouracil, doxorubicin,

OK-432 and 5-fluorouracil, doxorubicin, and mitomycin C (FAM-P) versus FAM chemotherapy in patients with curatively resected gastric carcinoma : A randomized Phase III trial

✍ Si-Young Kim; Ho C. Park; Choong Yoon; Hwi J. Yoon; Yong M. Choi; Kyung S. Cho 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 100 KB 👁 1 views

## BACKGROUND. The streptococcal agent OK-432 is used widely as a potent biologic response modifier. Accumulated evidence suggests that OK-432 exerts antineoplastic effects by a direct cytotoxic or inhibitory effect on tumor cells. The clinical efficacy of OK-432 has been reported for various tumor

Mitomycin C, doxorubicin and 5-fluoroura

Mitomycin C, doxorubicin and 5-fluorouracil may not improve survival over 5-fluorouracil alone in people with curatively resected gastric cancer: Abstracted from: Chang H, Jung K, Kim T et al. A phase III randomized trial of 5-fluorouracil, doxorubicin, and mitomycin C versus 5-fluorouracil and mitomycin C versus 5-fluorouracil alone in curatively resected gastric cancer. Annals of Oncology 2002; 13: 1779–85

✍ Qingguo Fu 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 65 KB

Beneficial Effects of 5-Fluorouracil and

Beneficial Effects of 5-Fluorouracil and Heparin-Based Portal Infusion Chemotherapy Combined with Mitomycin C and Cisplatin after Curative Resection of Pancreatic Cancer

✍ Aiura, Koichi; Takahashi, Shin; Matsui, Junichi; Ueda, Masakazu; Kitagawa, Yuko 📂 Article 📅 2010 🏛 S. Karger AG 🌐 English ⚖ 142 KB

Chemotherapy for hormonally refractory a

Chemotherapy for hormonally refractory advanced prostate carcinoma. A Comparison of combined versus sequential treatment with mitomycin C, doxorubicin, and 5-fluorouracil

✍ John A. Laurie; Richard G. Hahn; Terry M. Therneau; Shreyaskumar R. Patel; James 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 398 KB 👁 2 views

One hundred forty-two patients with progressive, hormonally refractory advanced prostate carcinoma who had not received prior chemotherapy were randomized to receive either combination chemotherapy with 5-fluorouracil(5-FU), doxorubicin, and mitomycin C (FAM) or sequential chemotherapy with the same

Anticancer drug distribution in lymph an

Anticancer drug distribution in lymph and blood during adjuvant chemotherapy after surgery for gastric carcinoma. A study with a combined preparation of 1-(2-tetrahydrofuryl)-5-fluorouracil and uracil

✍ Hitoshi Hanaue; Tsutomu Kurosawa; Yoshiaki Kitano; Sadaaki Miyakawa; Akihisa Nem 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 477 KB 👁 2 views